Skip to main content
Year archive

PCI Biotech Holding — 2018 filings

All 87 regulatory filings released by PCI Biotech Holding (PCIB) in 2018, sourced directly from the official regulator.

87 Filings
2018 Period
2018 filings (87)
Filing Released Lang
PCI Biotech: Preliminary confirmation of safety read-out from the fimaChem Phase I extension study in bile duct cancer
Earnings Release Q4 2018
2018-12-20 English
PCI Biotech: Preliminary confirmation of safety read-out from the fimaChem Phase I extension study in bile duct cancer
Regulatory Filings
2018-12-20 English
PCI Biotech: Extension of preclinical research collaboration agreement with a top-10 large pharma company
M&A Activity
2018-12-18 English
PCI Biotech: Extension of preclinical research collaboration agreement with a top-10 large pharma company
Regulatory Filings
2018-12-18 English
PCI Biotech: Third quarter 2018 results
Report Publication Announcement Q3 2018
2018-11-13 English
PCI Biotech: Third quarter 2018 results
Investor Presentation
2018-11-13 English
PCI Biotech: Third quarter 2018 results
Interim / Quarterly Report Q3 2018
2018-11-13 English
PCI Biotech: Third quarter 2018 results
Earnings Release Q3 2018
2018-11-13 English
PCI Biotech: Invitation to third quarter 2018 presentation
Report Publication Announcement
2018-11-06 English
PCI Biotech: Invitation to third quarter 2018 presentation
Report Publication Announcement
2018-11-06 English
PCI Biotech: Capital increase registered and listing of new shares
Share Issue/Capital Change
2018-10-24 English
PCI Biotech: Capital increase registered and listing of new shares
Share Issue/Capital Change
2018-10-24 English
PCI Biotech to present Phase I dose escalation results at ESMO
Regulatory Filings
2018-10-19 English
PCI Biotech to present Phase I dose escalation results at ESMO
Regulatory Filings
2018-10-19 English
PCI Biotech: Exercise of employee share options, mandatory noticifation of trade and resolution to increase share capital
Remuneration Information
2018-10-17 English
PCI Biotech: Exercise of employee share options, mandatory noticifation of trade and resolution to increase share capital
Director's Dealing
2018-10-17 English
Disclosure of large shareholding
Major Shareholding Notification
2018-10-10 English
Disclosure of large shareholding
Major Shareholding Notification
2018-10-10 English
PCI Biotech: Capital increase registered and listing of new shares
Capital/Financing Update
2018-10-10 English
PCI Biotech: Capital increase registered and listing of new shares
Capital/Financing Update
2018-10-10 English
PCI Biotech: Final results of the rights issue
Share Issue/Capital Change
2018-10-04 English
PCI Biotech: Last day of subscription period
Share Issue/Capital Change
2018-10-03 English
PCI Biotech: Last day of subscription period
Share Issue/Capital Change
2018-10-03 English
PCIB T - Siste noteringsdag i dag
Regulatory Filings
2018-10-01 Danish
PCIB T - Last day of listing today
Delisting Announcement
2018-10-01 English
PCI Biotech: Last day of trading in subscription rights Monday 01 October 2018
Capital/Financing Update
2018-09-28 English
PCI Biotech: Last day of trading in subscription rights Monday 01 October 2018
Report Publication Announcement
2018-09-28 English
Financial calendar
Report Publication Announcement
2018-09-25 English
Disclosure of large shareholdings
Director's Dealing
2018-09-24 English
Disclosure of large shareholdings
Major Shareholding Notification
2018-09-24 English
PCI Biotech: Mandatory notification regarding exercise and trade of subscription rights
Director's Dealing
2018-09-20 English
PCI Biotech: Mandatory notification regarding exercise and trade of subscription rights
Share Issue/Capital Change
2018-09-20 English
PCI Biotech: Mandatory notification regarding exercise and trade of subscription rights
Share Issue/Capital Change
2018-09-19 English
Oslo Børs - Tegningsrettene i PCI Biotech Holding ASA vil bli notert / The subscription rights in PCI Biotech Holding ASA will be listed 19.09.2018
Share Issue/Capital Change
2018-09-19 Norwegian
PCI Biotech: Commencement of subscription period
Share Issue/Capital Change
2018-09-19 English
PCI Biotech: Commencement of subscription period
Capital/Financing Update
2018-09-19 English
PCI Biotech: Commencement of subscription period
Share Issue/Capital Change
2018-09-19 English
Oslo Børs - Tegningsrettene i PCI Biotech Holding ASA vil bli notert / The subscription rights in PCI Biotech Holding ASA will be listed 19.09.2018
Share Issue/Capital Change
2018-09-18 Norwegian
PCI Biotech: Prospectus approved
Capital/Financing Update
2018-09-17 English
Ex fortrinnsretter i dag
Share Issue/Capital Change
2018-09-17 Norwegian
Ex preferential rights today
Share Issue/Capital Change
2018-09-17 English
PCI Biotech: Rights issue approved by the extraordinary general meeting
AGM Information
2018-09-14 Norwegian
PCI Biotech: Rights issue approved by the extraordinary general meeting
Share Issue/Capital Change
2018-09-14 English
PCI Biotech: Disclosure of voting rights for Chairman of the Board
Declaration of Voting Results & Voting Rights Announcements
2018-09-13 English
PCI Biotech: Second quarter and first half-year 2018 results
Interim / Quarterly Report H1 2018
2018-08-30 English
PCI Biotech: Second quarter and first half-year 2018 results
Investor Presentation
2018-08-30 English
PCI Biotech: Second quarter and first half-year 2018 results
Earnings Release H1 2018
2018-08-30 English
Key information relating to the preferential rights issue to be carried out by PCI Biotech Holding ASA
Capital/Financing Update
2018-08-24 English
PCI Biotech: Notice of Extraordinary General Meeting
AGM Information
2018-08-24 English
PCI Biotech: Notice of Extraordinary General Meeting
AGM Information
2018-08-24 English
PCI Biotech convenes an extraordinary general meeting to propose a fully underwritten Rights Issue of NOK 360 million
Regulatory Filings
2018-08-24 Norwegian
PCI Biotech convenes an extraordinary general meeting to propose a fully underwritten Rights Issue of NOK 360 million
Share Issue/Capital Change
2018-08-24 English
PCI Biotech: Invitation to first half year 2018 presentation
Report Publication Announcement
2018-08-23 English
PCI Biotech initiates research collaboration with Bavarian Nordic
Regulatory Filings
2018-08-20 English
Financial calendar
Report Publication Announcement
2018-06-28 English
PCI Biotech: Extension of preclinical research collaboration agreement with a top-10 large pharma company
Regulatory Filings
2018-06-15 English
Flaggemelding
Major Shareholding Notification
2018-06-06 Norwegian
PCI Biotech: Minutes from Annual General Meeting 2018
AGM Information
2018-05-29 English
PCI Biotech: Minutes from Annual General Meeting 2018
AGM Information
2018-05-29 English
PCI Biotech: Disclosure of voting rights for Chairman of the Board
Declaration of Voting Results & Voting Rights Announcements
2018-05-28 English
PCI Biotech initiates research collaboration with IMV Inc
Regulatory Filings
2018-05-24 English
PCI Biotech to present at BioEquity Europe
Regulatory Filings
2018-05-15 English
PCI Biotech: Notice of Annual General Meeting 2018
Board/Management Information
2018-05-08 English
PCI Biotech: Notice of Annual General Meeting 2018
AGM Information
2018-05-08 English
PCI Biotech: Notice of Annual General Meeting 2018
Remuneration Information
2018-05-08 English
PCI Biotech: Notice of Annual General Meeting 2018
Governance Information
2018-05-08 English
PCI Biotech: Notice of Annual General Meeting 2018
AGM Information
2018-05-08 English
PCI Biotech: First quarter 2018 report and presentation
Investor Presentation
2018-05-08 English
PCI Biotech: First quarter 2018 report and presentation
Interim / Quarterly Report Q1 2018
2018-05-08 English
PCI Biotech: First quarter 2018 report and presentation
Report Publication Announcement Q1 2018
2018-05-08 English
PCI Biotech: Invitation to first quarter 2018 presentation
Report Publication Announcement
2018-05-02 English
Oslo Børs - PCI Biotech Holding ASA will be transferred to Oslo Børs from 27.04.2018
Delisting Announcement
2018-04-27 English
Oslo Børs - PCI Biotech Holding ASA will be transferred to Oslo Børs from 27.04.2018
Regulatory Filings
2018-04-26 English
PCI Biotech: Publication of prospectus summary for transfer of listing to Oslo Børs
Delisting Announcement
2018-04-25 Norwegian
PCI Biotech: Publication of prospectus summary for transfer of listing to Oslo Børs
Report Publication Announcement
2018-04-25 English
Resolution of transfer of listing from Oslo Axess to Oslo Børs
Regulatory Filings
2018-04-25 English
PCI Biotech: Capital increase registered and listing of new shares
Share Issue/Capital Change
2018-04-17 English
PCI Biotech: Exercise of employee share options and resolution to increase the share capital
Share Issue/Capital Change
2018-04-12 English
Application for transfer of listing to Oslo Børs
Regulatory Filings
2018-03-21 English
PCI Biotech: Full year 2017 report - a transformative year
Investor Presentation
2018-03-20 English
PCI Biotech: Full year 2017 report - a transformative year
Audit Report / Information FY 2017
2018-03-20 English
PCI Biotech: Annual Report 2017
Annual Report FY 2017
2018-03-19 English
PCI Biotech: Annual Report 2017
Report Publication Announcement
2018-03-19 English
PCI Biotech: Invitation to full year 2017 presentation
Report Publication Announcement
2018-03-13 English
PCI Biotech to present at Bio-Europe Spring 2018
Regulatory Filings
2018-03-12 English
PCI Biotech: Extension of preclinical research collaboration agreement with a top-10 large pharma company
M&A Activity
2018-01-18 English
PCI Biotech to present at Biotech Showcase 2018
Regulatory Filings
2018-01-08 English